A detailed history of Harbour Investments, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Harbour Investments, Inc. holds 9,436 shares of LLY stock, worth $7.52 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
9,436
Previous 7,995 18.02%
Holding current value
$7.52 Million
Previous $7.24 Million 15.49%
% of portfolio
0.27%
Previous 0.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $1.11 Million - $1.38 Million
1,441 Added 18.02%
9,436 $8.36 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $171,069 - $214,533
236 Added 3.04%
7,995 $7.24 Million
Q1 2024

Jul 22, 2024

BUY
$592.2 - $792.28 $110,149 - $147,364
186 Added 2.46%
7,759 $6.04 Million
Q4 2023

Feb 16, 2024

BUY
$525.19 - $619.13 $681,171 - $803,011
1,297 Added 20.67%
7,573 $4.41 Million
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $239,085 - $329,615
-550 Reduced 8.06%
6,276 $3.37 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $61,379 - $82,071
175 Added 2.63%
6,826 $3.2 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $34,790 - $40,859
112 Added 1.71%
6,651 $2.28 Million
Q4 2022

Feb 15, 2023

BUY
$321.55 - $374.67 $997,769 - $1.16 Million
3,103 Added 90.31%
6,539 $2.39 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $1.35 Million - $1.58 Million
-4,836 Reduced 58.46%
3,436 $1.11 Million
Q4 2021

Feb 16, 2022

SELL
$224.85 - $279.04 $414,848 - $514,828
-1,845 Reduced 18.24%
8,272 $2.29 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $292,068 - $359,431
-1,318 Reduced 11.53%
10,117 $2.34 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $31,235 - $40,402
-173 Reduced 1.49%
11,435 $2.63 Million
Q1 2021

Aug 17, 2021

BUY
$164.32 - $212.72 $1.69 Million - $2.19 Million
10,308 Added 792.92%
11,608 $2.17 Million
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $213,616 - $276,536
1,300 New
1,300 $243,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.